Answers are grounded in this paper and cite their sources.
A 72-year-old man presented with a tentative diagnosis of acute leukemia. His white cell count was 7.59 × 103/µL, including 15.0% leukemic cells with immature morphology. Lactate dehydrogenase value was 4,243 IU/L. The bone marrow biopsy showed ‘packed’ marrow infiltration of leukemic cells. The cells were CD5−, CD10+, CD19+, CD20+, and surface immunoglobulin γλ+ by flow cytometry, and BCL2+, BCL6−, and MUM1− by immunohistochemistry. 18Fluorodeoxyglucose-positron emission tomography combined with computed tomography showed heterogeneous tracer uptake throughout the bone marrow space. G-banding of leukemia cells revealed a hyperdiploid karyotype with two copies of t(14;18)(q32;q21), and fluorescence in situ hybridization of interphase nuclei confirmed the double t(14;18)(q32;q21). There was no 8q24/MYC rearrangement. Long-distance polymerase chain reaction generated a 2.6 kilobase-pair product, encompassing the major breakpoint cluster of BCL2, N-like segments, and the J5 segment of the immunoglobulin heavy chain gene. Although, the patient initially responded to chemotherapy, he relapsed shortly and died of disease progression. This case represents a rare presentation of follicular lymphoma, in which transformation to aggressive disease occurred de novo without a preceding indolent phase. It is possible that the double t(14;18)(q32;q21) may have generated a higher amount of BCL2 protein, thereby accounting, in part, for the progressive/refractory behavior of this case.
No takes yet. Share an insight, caveat, or question.
Toda et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: